We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+0.05%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$3.55B
AUM Growth
+$59.4M
Cap. Flow
+$77M
Cap. Flow %
2.17%
Top 10 Hldgs %
49.57%
Holding
665
New
156
Increased
155
Reduced
111
Closed
128

Top Buys

Rank Stock Value
1
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$138M
2
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
+$131M
3
EDR
Endeavor Group Holdings, Inc.
EDR
+$127M
4
MRO
Marathon Oil Corporation
MRO
+$123M
5
CHX
ChampionX
CHX
+$98.3M

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$638M
2
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$51.2M
3
DFS
Discover Financial Services
DFS
+$45.1M
4
SCRM
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
+$18.4M
5
NSC icon
Norfolk Southern
NSC
+$17.7M

Sector Composition

Rank Sector Weight
1 Energy 26.53%
2 Technology 21.03%
3 Healthcare 14.68%
4 Industrials 8.19%
5 Materials 6.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSK icon
501
CALL
GSK
GSK
$106B
$7K ﹤0.01%
+70,000
New +$2.94M
HLT icon
502
PUT
Hilton Worldwide
HLT
$72.1B
$6.59K ﹤0.01%
15,500
– –
WDC icon
503
PUT
Western Digital
WDC
$149B
$6.31K ﹤0.01%
19,184
– –
BNAIW
504
Brand Engagement Network Warrant
BNAIW
$1.85M
$5.91K ﹤0.01%
153,567
– –
SRPT icon
505
PUT
Sarepta Therapeutics
SRPT
$1.76B
$5.63K ﹤0.01%
+15,000
New +$1.93M
MSAIW icon
506
MultiSensor AI Holdings Warrant
MSAIW
$755K
$5.01K ﹤0.01%
145,732
– –
VRNA
507
CALL
DELISTED
Verona Pharma
VRNA
$5K ﹤0.01%
+40,000
New +$584K
XFOR icon
508
CALL
X4 Pharmaceuticals
XFOR
$444M
$5K ﹤0.01%
+6,667
New +$218K
BRLSW icon
509
Borealis Foods Inc Warrant
BRLSW
$949K
$4.92K ﹤0.01%
72,293
– –
OPTXW icon
510
Syntec Optics Holdings Warrant
OPTXW
$16.6M
$4.38K ﹤0.01%
33,069
– –
BBIO icon
511
CALL
BridgeBio Pharma
BBIO
$16.2B
$4.38K ﹤0.01%
+35,000
New +$957K
CRSP icon
512
CALL
CRISPR Therapeutics
CRSP
$5.17B
$4.38K ﹤0.01%
25,000
+9,000
+56% +$521K
TRONW
513
DELISTED
Corner Growth Acquisition Corp. 2 Warrants
TRONW
$3.97K ﹤0.01%
116,665
– –
RMCOW icon
514
Royalty Management Holding Warrant
RMCOW
$1.49M
$3.85K ﹤0.01%
+226,579
New +$6K
MRK icon
515
CALL
Merck
MRK
$316B
$3.8K ﹤0.01%
+20,000
New +$2.58M
NTLA icon
516
CALL
Intellia Therapeutics
NTLA
$1.65B
$3.75K ﹤0.01%
30,000
+5,000
+20% +$119K
TVGNW icon
517
Tevogen Inc. Warrant
TVGNW
$814K
$3.75K ﹤0.01%
185,416
– –
RVNC
518
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
$3K ﹤0.01%
+120,000
New +$410K
RDZNW icon
519
Roadzen Inc Warrants
RDZNW
$8.64M
$2.69K ﹤0.01%
67,181
– –
FNVTW
520
DELISTED
Finnovate Acquisition Corp. Warrants
FNVTW
$2.63K ﹤0.01%
130,406
– –
H icon
521
PUT
Hyatt Hotels
H
$16.8B
$2K ﹤0.01%
16,000
– –
ATEC icon
522
CALL
Alphatec Holdings
ATEC
$1.41B
$1K ﹤0.01%
+40,000
New +$466K
BLUA.WS
523
DELISTED
BlueRiver Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
BLUA.WS
$748 ﹤0.01%
49,521
– –
SEPAW
524
DELISTED
SEP Acquisition Corp Warrants
SEPAW
$663 ﹤0.01%
80,900
– –
WINVW
525
DELISTED
WinVest Acquisition Corp. Warrant
WINVW
$270 ﹤0.01%
18,392
– –
19 20
21
22 23

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q2 2024 Portfolio in Review

As of Q2 2024, UBS O'Connor held 665 positions worth $3.55B, up 1.7% from $3.49B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

UBS O'Connor's Q2 2024 filing shows 156 new, 155 increased, 111 reduced and 128 closed positions. Its largest new stake was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M. The largest sale was Pioneer Natural Resource Co., an estimated $638M.

By sector, the portfolio is most concentrated in Energy at 27% of assets, down from 34% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q2 2024 buy was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M.
  • UBS O'Connor added most to HashiCorp, Inc. Class A Common Stock in Q2 2024, an estimated $138M increase.
  • UBS O'Connor's biggest Q2 2024 reduction was Cerevel Therapeutics Holdings, Inc. Common Stock, cutting an estimated $51.2M.
  • UBS O'Connor fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $638M.
  • UBS O'Connor's ten largest holdings make up 50% of its $3.55B portfolio in Q2 2024.
  • UBS O'Connor opened 156 new positions and closed 128 in Q2 2024.
  • UBS O'Connor's portfolio value rose 1.7% quarter-over-quarter to $3.55B.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.